Pub Date : 2023-01-01DOI: 10.21608/amj.2023.273683
Background: Supracondylar fracture of the humerus is the second most frequent types of bone injury in children. For treatment of this fracture, closed reduction and percutaneous pinning, and open reduction and internal fixation were two common managements for supracondylar fracture of the humerus. Objective: To review systemically the efficacy of different pin configurations in management of supra condylar humeral fracture in children. Materials and methods: This was a systematic review about supra condylar humeral fracture in children managed by closed reduction and percutaneous pining. The search was conducted by using the databases: MEDLINE, Cochrane library and Google Scholar, PubMed, using the following keywords: "supracondylar, humerus, children, pinning," for published studies from 2010-2020. Result: The carrying angle loss was measured in three studies, 2 used lateral divergent pinning and showed excellent in about 96.6%, good (6.67%), and 1 used medio-lateral entry pin showed excellent (43.75%), good (50%), poor (6.25%), and this showed that lateral divergent pinning had better. As regard mean loss in elbow, extension was 2.4 in lateral divergent pinning, 8.2 in medio-lateral entry pin, 1.7 in lateral pin trans olecranon, and mean Baumann angle loss was 1.3 in lateral divergent pinning, 2.45 in medio-lateral entry pin 4.3 in infrafocal pin. Conclusion: Our review after studying the four type of pinning fixations we found that lateral divergent pinning had better outcome and lower complications. Hence, lateral divergent pinning is the favored procedure.
{"title":"SYSTEMATIC REVIEW OF SUPRA CONDYLAR HUMERAL FRACTURE IN CHILDREN MANAGED BY CLOSED REDUCTION AND PERCUTANEOUS PINNING: REVIEW ARTICLE","authors":"","doi":"10.21608/amj.2023.273683","DOIUrl":"https://doi.org/10.21608/amj.2023.273683","url":null,"abstract":"Background: Supracondylar fracture of the humerus is the second most frequent types of bone injury in children. For treatment of this fracture, closed reduction and percutaneous pinning, and open reduction and internal fixation were two common managements for supracondylar fracture of the humerus. Objective: To review systemically the efficacy of different pin configurations in management of supra condylar humeral fracture in children. Materials and methods: This was a systematic review about supra condylar humeral fracture in children managed by closed reduction and percutaneous pining. The search was conducted by using the databases: MEDLINE, Cochrane library and Google Scholar, PubMed, using the following keywords: \"supracondylar, humerus, children, pinning,\" for published studies from 2010-2020. Result: The carrying angle loss was measured in three studies, 2 used lateral divergent pinning and showed excellent in about 96.6%, good (6.67%), and 1 used medio-lateral entry pin showed excellent (43.75%), good (50%), poor (6.25%), and this showed that lateral divergent pinning had better. As regard mean loss in elbow, extension was 2.4 in lateral divergent pinning, 8.2 in medio-lateral entry pin, 1.7 in lateral pin trans olecranon, and mean Baumann angle loss was 1.3 in lateral divergent pinning, 2.45 in medio-lateral entry pin 4.3 in infrafocal pin. Conclusion: Our review after studying the four type of pinning fixations we found that lateral divergent pinning had better outcome and lower complications. Hence, lateral divergent pinning is the favored procedure.","PeriodicalId":84126,"journal":{"name":"Al Azhar medical journal = Majallat al-Tibb al-Azhar","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49206242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.21608/amj.2023.273674
{"title":"COMPARATIVE STUDY BETWEEN EFFECT OF CLOMIPHENE CITRATE, TAMOXIFEN AND LETROZOLE ON ENDOMETRIAL THICKNESS IN INDUCTION OF OVULATION","authors":"","doi":"10.21608/amj.2023.273674","DOIUrl":"https://doi.org/10.21608/amj.2023.273674","url":null,"abstract":"","PeriodicalId":84126,"journal":{"name":"Al Azhar medical journal = Majallat al-Tibb al-Azhar","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46640406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.21608/amj.2023.273680
{"title":"ASTHMA PHENOTYPE, BIOMARKERS ESSENTIAL FOR THE DIAGNOSIS AND TREATMENT OF SEVERE ASTHMA","authors":"","doi":"10.21608/amj.2023.273680","DOIUrl":"https://doi.org/10.21608/amj.2023.273680","url":null,"abstract":"","PeriodicalId":84126,"journal":{"name":"Al Azhar medical journal = Majallat al-Tibb al-Azhar","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42086526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.21608/amj.2023.273676
Background: Corneal neovascularization (NV) can occur as a consequence of anterior segment inflammation, injury and ischemia. This pathological response can cause visual impairment or other conditions such as corneal edema, corneal scarring, lipid deposition, increased risk of graft rejection after corneal transplantation, and bleeding during corneal flap preparation in laser in situ keratomileusis (LASIK) surgery. Many studies have shown that anti-vascular endothelial growth factor agents can inhibit corneal neovascularization. One such inhibitor is bevacizumab, a humanized murine monoclonal antibody against all vascular endothelial growth factor isoforms. Objective: To evaluate the results of using topical bevacizumab (Avastin) as a treatment of corneal neovascularization due to different causes. Patients and methods: In this study, Bevacizumab was used topically as eye drops with a concentration of 0.5 mg/ml. Total 30 eyes were included in this study. All were diagnosed with corneal neovascularization. Careful history was taken from all patients and they underwent ophthalmological examination including slit lamp biomicroscopy examination , color photos of the anterior segment and intra oculae pressure . All cases were selected from outpatient clinic of the Ophthalmology Department at Al-Azhar University Hospital (Cairo) from October 2018 to October 2020. Results: The corneal opacity decreased in 13.3% of the studied group. However, the remaining 86.7% didn’t show any change at all. The best corrected visual acuity (BCVA) improved in about one third of the studied group (33.3%). However, the remaining 66.7% didn’t show any change at all. There was ahighly significant difference between the studied group as regarding effect of Avastin on neovascularization after one and two weeks. It was noticed that moderate response increased from the first to the second week (3.3% versus 56.7% respectively). There were highly statistically significant differences between the different pathologies as regarding Avastin’s effect on corneal neovascularization after both one and two weeks. Conclusion: The use of topical bevacizumab (avastin) eye drops in cases of corneal NV was safe, well tolerated, associated with mild to moderate regression of corneal NV and not associated by any drug related side effects.
{"title":"OUT COME OF THE USE OF TOPICAL BEVACIZUMAB IN TREATMENT OF CORNEAL NEOVASCULARIZATION","authors":"","doi":"10.21608/amj.2023.273676","DOIUrl":"https://doi.org/10.21608/amj.2023.273676","url":null,"abstract":"Background: Corneal neovascularization (NV) can occur as a consequence of anterior segment inflammation, injury and ischemia. This pathological response can cause visual impairment or other conditions such as corneal edema, corneal scarring, lipid deposition, increased risk of graft rejection after corneal transplantation, and bleeding during corneal flap preparation in laser in situ keratomileusis (LASIK) surgery. Many studies have shown that anti-vascular endothelial growth factor agents can inhibit corneal neovascularization. One such inhibitor is bevacizumab, a humanized murine monoclonal antibody against all vascular endothelial growth factor isoforms. Objective: To evaluate the results of using topical bevacizumab (Avastin) as a treatment of corneal neovascularization due to different causes. Patients and methods: In this study, Bevacizumab was used topically as eye drops with a concentration of 0.5 mg/ml. Total 30 eyes were included in this study. All were diagnosed with corneal neovascularization. Careful history was taken from all patients and they underwent ophthalmological examination including slit lamp biomicroscopy examination , color photos of the anterior segment and intra oculae pressure . All cases were selected from outpatient clinic of the Ophthalmology Department at Al-Azhar University Hospital (Cairo) from October 2018 to October 2020. Results: The corneal opacity decreased in 13.3% of the studied group. However, the remaining 86.7% didn’t show any change at all. The best corrected visual acuity (BCVA) improved in about one third of the studied group (33.3%). However, the remaining 66.7% didn’t show any change at all. There was ahighly significant difference between the studied group as regarding effect of Avastin on neovascularization after one and two weeks. It was noticed that moderate response increased from the first to the second week (3.3% versus 56.7% respectively). There were highly statistically significant differences between the different pathologies as regarding Avastin’s effect on corneal neovascularization after both one and two weeks. Conclusion: The use of topical bevacizumab (avastin) eye drops in cases of corneal NV was safe, well tolerated, associated with mild to moderate regression of corneal NV and not associated by any drug related side effects.","PeriodicalId":84126,"journal":{"name":"Al Azhar medical journal = Majallat al-Tibb al-Azhar","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44092191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.21608/amj.2023.273686
{"title":"METAMORPHOSIS IN BOTH CTG AND UMBILICAL ARTERY DOPPLER IN PATIENTS WITH SEVERE PREECLAMPSIA AFTER LOADING DOSE OF MAGNESIUM SULPHATE","authors":"","doi":"10.21608/amj.2023.273686","DOIUrl":"https://doi.org/10.21608/amj.2023.273686","url":null,"abstract":"","PeriodicalId":84126,"journal":{"name":"Al Azhar medical journal = Majallat al-Tibb al-Azhar","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45656399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.21608/amj.2023.276359
{"title":"PREDICTIVE VALUE OF THE CHA2DS2-VASC SCORE IN DETECTING IN-STENT RESTENOSIS AMONG PATIENTS WHO UNDERWENT PROXIMAL LEFT ANTERIOR DESCENDING ARTERY REVASCULARIZATION WITH DRUG ELUTING STENTS","authors":"","doi":"10.21608/amj.2023.276359","DOIUrl":"https://doi.org/10.21608/amj.2023.276359","url":null,"abstract":"","PeriodicalId":84126,"journal":{"name":"Al Azhar medical journal = Majallat al-Tibb al-Azhar","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46456098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.21608/amj.2023.274297
{"title":"NEBULIZED AMIKACIN AS AN ADJUVANT THERAPY IN GRAM-NEGATIVE PULMONARY INFECTIONS IN CHEST CARE UNIT","authors":"","doi":"10.21608/amj.2023.274297","DOIUrl":"https://doi.org/10.21608/amj.2023.274297","url":null,"abstract":"","PeriodicalId":84126,"journal":{"name":"Al Azhar medical journal = Majallat al-Tibb al-Azhar","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48614033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：